Sandra L. Kweder graduated from the University of Connecticut in 1979 and attended the University of North Carolina’s School of Public Health in Chapel Hill. She was commissioned in the U.S. Public Health Service in 1980 upon entering the Uniformed Services University of Health Sciences (USUHS) and retired her uniform in 2013. Following internal medicine training at Walter Reed Army Medical Center she joined the U.S. Food & Drug Administration (FDA) as a medical reviewer in the Division of Antiviral Drugs early in her career to address the growing field of HIV drug development. She has since held a number of positions, including leadership of the Division of Postmarketing Surveillance & Epidemiology and the Office of Antimicrobial Products and spent two years on sabbatical at Brown University as a clinical fellow in Obstetric and Consultative Medicine. She has been Deputy Director, Office of New Drugs (OND) in FDA’s Center for Drug Evaluation & Research (CDER) since 2002.